Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Idun Pharmaceuticals
company
About
IDUN Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of human therapeutics to control
- 51 - 100
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $22.80M
- Industries
- Biopharma,Biotechnology,Therapeutics
- Founded date
- Jan 1, 1993
- Number Of Employee
- 51 - 100
- Operating Status
- Active
IDUN Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of human therapeutics to control apoptosis. Its products under Phase 2 and preclinical trials include drugs for liver disease, CNS diseases, inflammation, and cancer, as well as IDN-6556 for the treatment of liver diseases in patients infected with Hepatitis C virus. The company was founded in 1993 and is based in San Diego, California. As of July 30, 2010, IDUN Pharmaceuticals, Inc. operates as a subsidiary of Conatus Pharmaceuticals Inc.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$49.80M
Idun Pharmaceuticals has raised a total of
$49.80M
in funding over 2 rounds. Their latest funding was raised on
Jun 20, 2004 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 20, 2004 | Series Unknown | $27M | 1 | — | — | Detail |
| Dec 9, 2002 | Series A | $22.80M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Idun Pharmaceuticals is funded by 2 investors.
Pacific Rim Ventures
and ARCH Venture Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Pacific Rim Ventures
|
— | Series Unknown |
ARCH Venture Partners
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
